Winton Group’s Larimar Therapeutics LRMR Stock Holding History

Winton Group’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,204	Closed	-$140K	–	1527
2020 Q1	$140K	Sell	15,204 -126	-0.8%	-$1.66K	﹤0.01%	1295
2019 Q4	$204K	Buy	15,330 +2,010	+15%	+$19.2K	﹤0.01%	1440
2019 Q3	$118K	Buy	+13,320	New	+$146K	﹤0.01%	1451

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return